Caricamento...
Epigenetic therapy for ovarian cancer: promise and progress
Ovarian cancer is the deadliest gynecologic malignancy, with a 5-year survival rate of approximately 47%, a number that has remained constant over the past two decades. Early diagnosis improves survival, but unfortunately only 15% of ovarian cancers are diagnosed at an early or localized stage. Most...
Salvato in:
| Pubblicato in: | Clin Epigenetics |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6334391/ https://ncbi.nlm.nih.gov/pubmed/30646939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0602-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|